2-(2-((5-(1H-indol-2-yl)-1H-pyrrol-2-yl)methylene)-3-methoxy-2H-pyrrol-5-yl)-1H-indole

ID: ALA2172439

PubChem CID: 71453582

Max Phase: Preclinical

Molecular Formula: C26H20N4O

Molecular Weight: 404.47

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1ccc(-c2cc3ccccc3[nH]2)[nH]1

Standard InChI:  InChI=1S/C26H20N4O/c1-31-26-15-24(23-13-17-7-3-5-9-20(17)29-23)30-25(26)14-18-10-11-21(27-18)22-12-16-6-2-4-8-19(16)28-22/h2-15,27-29H,1H3/b25-14-

Standard InChI Key:  GPFILPCGIWGAGV-QFEZKATASA-N

Molfile:  

     RDKit          2D

 31 36  0  0  0  0  0  0  0  0999 V2000
   18.9699  -25.0401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1804  -25.8284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9951  -25.8719    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.2883  -25.1103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6546  -24.5964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0778  -24.8995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6551  -25.4778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6980  -23.7804    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.4265  -23.4100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5233  -26.2801    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.2511  -26.6517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8294  -26.0743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4590  -25.3460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6678  -26.4668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8517  -26.4234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8785  -27.2564    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.1929  -27.7009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5618  -27.1845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8011  -27.4730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6703  -28.2777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3062  -28.7930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0645  -28.5017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3790  -27.4590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8007  -28.0364    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.1068  -27.8306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9784  -28.6377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1747  -28.7621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8822  -29.5190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3923  -30.1520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1985  -30.0232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4873  -29.2664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  1  2  0
  4  6  2  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  7 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  7  2  0
 14 15  2  0
 15 18  1  0
 17 16  1  0
 16 14  1  0
  2 14  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 23 24  1  0
 24 27  1  0
 26 25  1  0
 25 23  2  0
 11 23  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
M  END

Associated Targets(Human)

PTPN6 Tchem Protein-tyrosine phosphatase 1C (687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 404.47Molecular Weight (Monoisotopic): 404.1637AlogP: 6.02#Rotatable Bonds: 4
Polar Surface Area: 68.96Molecular Species: NEUTRALHBA: 2HBD: 3
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.87CX Basic pKa: 4.56CX LogP: 4.02CX LogD: 4.02
Aromatic Rings: 5Heavy Atoms: 31QED Weighted: 0.34Np Likeness Score: 0.11

References

1. Su JC, Chen KF, Chen WL, Liu CY, Huang JW, Tai WT, Chen PJ, Kim I, Shiau CW..  (2012)  Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists.,  56  [PMID:22982119] [10.1016/j.ejmech.2012.08.024]

Source